[Federal Register Volume 66, Number 201 (Wednesday, October 17, 2001)]
[Notices]
[Pages 52780-52781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26017]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 23, 2001, B.I. Chemical 
Inc., 2820 N. Normandy Drive,

[[Page 52781]]

Petersburg, Virginia 23805, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
Amphetamine (1100).........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Levo-alphacetylmethadol (LAAM) (9648)......  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture the listed controlled substances 
for formulation into finished pharmaceuticals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 17, 2001.

    Dated: October 5, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-26017 Filed 10-16-01; 8:45 am]
BILLING CODE 4410-09-M